Patent settlements go before Supreme Court on March 25

03/7/2013 | Philadelphia Inquirer, The

Generic and brand-name drugmakers are set for a March 25 Supreme Court case in which federal officials argue that drug prices would be reduced without patent settlements. The case "will define how an entire industry does business," Generic Pharmaceutical Association President Ralph Neas said. An unfavorable ruling will be bad for drugmakers, taxpayers and consumers, he said.

View Full Article in:

Philadelphia Inquirer, The

Published in Briefs: